Related Experiment Video
Updated: Apr 17, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Does Sickle Cell Disease Protect Against Diabetes Mellitus?: Cross-sectional study
Ali A Suwaidan1, Fathia Al-Qurashi2, David L Whitford3
1School of Medicine, Royal College of Surgeons in Ireland Medical University of Bahrain, Busaiteen, Bahrain.
Insights
The prevalence of diabetes mellitus (DM) in sickle cell disease (SCD) patients in Bahrain was 8.3%. Although high, this rate is lower than anticipated, suggesting SCD may offer some protection against DM.
Area of Science:
- Hematology
- Endocrinology
- Public Health
Background:
- Co-existence of diabetes mellitus (DM) and sickle cell disease (SCD) is uncommon.
- Bahrain has a high prevalence of DM, making the DM rate in SCD patients a significant public health question.
Purpose of the Study:
- To determine the prevalence of DM in adult SCD patients in Bahrain.
- To compare DM prevalence in SCD patients to the general population.
Main Methods:
- Cross-sectional study of 2,204 adult SCD patients from 2003-2010.
- DM prevalence assessed via laboratory records in a random sample of 520 patients.
Main Results:
- 24 out of 376 SCD patients (6.4%) had DM.
- Age- and sex-standardized DM prevalence was 8.3% in the SCD cohort.
Conclusions:
- DM prevalence in Bahraini SCD patients is high but lower than expected.
- Sickle cell disease might confer a protective effect against DM development.
- Concurrent DM and SCD necessitate screening and aggressive management due to vascular disease risks.
Objectives:
The co-existence of diabetes mellitus (DM) and sickle cell disease (SCD) is rare. This study aimed to explore whether SCD patients have the same DM prevalence as the general population in a country with a high prevalence of DM.
Methods:
This cross-sectional study included all SCD adult patients admitted to Salmaniya Medical Complex, Bahrain, between 2003 and 2010 (n = 2,204). A random sample (n = 520) was taken to establish the prevalence of DM. Laboratory records were examined to determine the presence of DM.
Results:
There were 376 SCD patients with complete records; of these, 24 (6.4%) had DM. The age- and sex-standardised prevalence of DM was 8.3%.
Conclusion:
While the prevalence of DM in SCD patients in Bahrain was high, it was lower than expected in this population. SCD may have a protective effect towards DM development. However, the impact of these two conditions on vascular diseases suggest a need for screening and aggressive treatment in this population.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Psychoneuroimmunology: Diabetes and Cancer

